1. At a Glance
Welcome to the land of credit, karma, and curious compliance – CARE Ratings Ltd, where every balance sheet has a backstory and every “AA+” hides a tiny existential crisis. The company reported a Q2FY26 consolidated revenue of ₹136.37 crore and a PAT of ₹56.7 crore, showing a healthy 23% YoY profit growth. The share price, however, at ₹1,597, seems to be meditating in its own peace zone, down ~1% over three months, possibly practicing long-term yoga with SEBI’s patience.
With a market cap of ₹4,794 crore, P/E of 31.4, ROE of 18%, and ROCE of 24.6%, CARE sits comfortably in the elite “no-debt, high-dividend, low-drama” club. Its debt-to-equity ratio of just 0.03 screams fiscal celibacy. A 60.5% dividend payout ratio means it’s not shy about sharing profits either — almost like an Indian dad showing off his son’s marksheet at a family function.
As the Bhagavad Gita wisely says, “Karmanye vadhikaraste ma phaleshu kadachana” — do your ratings without attachment to the outcome. CARE, it seems, has taken that literally: it rates thousands of companies yet refuses to judge its own share price.
2. Introduction
Let’s be honest — “credit rating agency” doesn’t exactly sound like the kind of business that gets you likes on Instagram. It’s not flashy, it’s not sexy, but it’s the quiet backbone of India’s debt markets. CARE Ratings has been around since 1993, and much like that one overachiever in school who aced every exam until a scandal broke out in 2019, it’s been on a redemption arc ever since.
The company once faced SEBI’s wrath with a ₹1 crore penalty for its IL&FS rating blunder, and oh boy, has it been working overtime to clean that up. Post-2020, it introduced AI-powered fraud detection tools, formed partnerships with Tresata, and even launched its own ESG platform, SIRIUS — which sounds like a Harry Potter spell but actually measures corporate sustainability.
Under MD & CEO Mehul Pandya, CARE Ratings is regaining lost market share, pushing hard into non-rating businesses, and trying to make rating sound… well, less boring. And it’s working. With a profit growth of 33.7% and sales growth of 19.5% in the latest TTM, CARE is slowly transforming from “that IL&FS guy” to “the ESG rating pioneer” of India.
But here’s the kicker: despite the revival, FIIs now own nearly 24%, DIIs 31.6%, and retail public around 44.8%. No promoter drama, no pledges, just pure institutional trust. How many Indian companies can say that without blushing?
3. Business Model – WTF Do They Even Do?
CARE Ratings is like your CA friend who charges you for telling you your credit card bill is too high — except it does that
